Unknown × Interventional × Chemotherapy, Adjuvant × Clear all A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation
Phase 2 Unknown
29 enrolled
Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC
Phase 3 Unknown
420 enrolled
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk
Phase 2 Unknown
150 enrolled
Total Neoadjuvant Therapy in Rectal Cancer Treatment
Phase 4 Unknown
280 enrolled
Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma
Phase 2 Unknown
78 enrolled
LUNG ART
Phase 3 Unknown
500 enrolled
The Clinical Study of Adjuvant Chemotherapy on Intestinal and Urethral Flora in Patients With Gastric and Colon Cancer
Phase NA Unknown
120 enrolled
EHTASEOCCS
Phase 3 Unknown
310 enrolled
Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy
Phase 2 Unknown
99 enrolled
REALIZATION
Phase 2 Unknown
102 enrolled
EPHOS-B
Phase 3 Unknown
257 enrolled
TACT2
Phase 3 Unknown
4,400 enrolled
TNTCRT
Phase 3 Unknown
458 enrolled
EHNPCTASEOC
Phase 3 Unknown
263 enrolled
Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy
Phase NA Unknown
1 enrolled
ST03
Phase 2/3 Unknown
1,103 enrolled
HIPEC
Phase 3 Unknown
640 enrolled
Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection
Phase 3 Unknown
290 enrolled
Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer
Phase 2 Unknown
230 enrolled
Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer
Phase 3 Unknown
486 enrolled
Randomized Control Trial on Efficacy and Safety of Concurrent and Adjuvant Chemotherapy for the Cervical Cancer
Phase 3 Unknown
598 enrolled
A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
Phase NA Unknown
20 enrolled
A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection.
Phase 3 Unknown
588 enrolled
Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer
Phase NA Unknown
464 enrolled
Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma
Phase 3 Unknown
1,258 enrolled
Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy
Phase 3 Unknown
550 enrolled
Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor
Phase 3 Unknown
350 enrolled
Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
Phase 3 Unknown
316 enrolled
Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma
Phase 2 Unknown
57 enrolled
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
Phase 2 Unknown
50 enrolled
Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
Phase 2 Unknown
200 enrolled
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
Phase 2 Unknown
80 enrolled
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
Phase 2 Unknown
20 enrolled
Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma
Phase 2 Unknown
Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
Phase NA Unknown
75 enrolled
Tamoxifen in Treating Women With Breast Cancer
Phase 3 Unknown
20,000 enrolled
Lymphocyte Therapy in Treating Patients With Kidney Cancer
Phase 2 Unknown
90 enrolled
Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer
Phase 3 Unknown
R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
Phase 2 Unknown
Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Phase 3 Unknown
700 enrolled
Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed
Phase 3 Unknown
750 enrolled
Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer
Phase 3 Unknown
300 enrolled
Combination Chemotherapy in Treating Patients With Colon Cancer
Phase 3 Unknown
800 enrolled
Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors
Phase 2 Unknown
30 enrolled
S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer
Phase 2 Unknown
50 enrolled
S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer
Phase 2 Unknown
70 enrolled
Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors
Phase 3 Unknown
105 enrolled
Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery
Phase 2 Unknown
29 enrolled
Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer
Phase 2 Unknown
47 enrolled
High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma
Phase 2 Unknown
29 enrolled